Liang Yao

Liang Yao

Auto-generated profile, based on publicly available information

Liang Yao

Department of Health Research Methods, Evidence and Impact at McMaster University, Hamilton, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2023 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
AKAliya A. Khan
Aliya A. Khan
Maria Luisa BrandiMaria Luisa Brandi
Maria Luisa Brandi
EREric T. Rush
Eric T. Rush
DADalal Ali
Dalal Ali
HAHatim Al-Alwani
Hatim Al-Alwani
ELE. Michael Lewiecki
E. Michael Lewiecki
Background This manuscript provides a summary of the current evidence to support the criteria for diagnosing a child or adult with hypophosphatasia (HPP). The diagnosis of HPP is made on the basis of integrating clinical features, laboratory profile, radiographic features of the condition, and DNA analysis identifying the presence of a pathogenic variant of the tissue nonspecific alkaline phosphatase gene (ALPL). Often, the diagnosis of HPP is significantly delayed in both adults and children, and updated diagnostic criteria are required to keep pace with our evolving understanding regarding the relationship between ALPL genotype and associated HPP clinical features. Methods An International Working Group (IWG) on HPP was formed, comprised of a multidisciplinary team of experts from Europe and North America with expertise in the diagnosis and management of patients with HPP. Methodologists (Romina Brignardello-Petersen and Gordon Guyatt) and their team supported the IWG and conducted systematic reviews following the GRADE methodology, and this provided the basis for the recommendations. Results The IWG completed systematic reviews of the literature, including case reports and expert opinion papers describing the phenotype of patients with HPP. The published data are largely retrospective and include a relatively small number of patients with this rare condition. It is anticipated that further knowledge will lead to improvement in the quality of genotype-phenotype reporting in this condition. Conclusion Following consensus meetings, agreement was reached regarding the major and minor criteria that can assist in establishing a clinical diagnosis of HPP in adults and children.

13 May 2025 in BMJ
Verified
Journal Article
Closed access
Gordon GuyattGordon Guyatt
Gordon Guyatt
YWYing Wang
Ying Wang
PEPrashanti Eachempati
Prashanti Eachempati
AIAlfonso Iorio
Alfonso Iorio
MMM Hassan Murad
M Hassan Murad
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
AKAliya A. Khan
Aliya A. Khan
Gordon GuyattGordon Guyatt
Gordon Guyatt
DADalal Ali
Dalal Ali
JBJohn P. Bilezikian
John P. Bilezikian
MCMichael T. Collins
Michael T. Collins
LRLars Rejnmark
Lars Rejnmark
Hypoparathyroidism (HypoPT) is a rare disorder characterized by hypocalcemia in the presence of a low or inappropriately normal parathyroid hormone level. HypoPT is most commonly seen after neck surgery, which accounts for approximately 75% of cases, whereas approximately 25% have HypoPT due to nonsurgical causes. In both groups of patients, conventional therapy includes calcium and active vitamin D analogue therapy aiming to maintain serum calcium concentration in the low normal or just below the normal reference range and normalize serum phosphorus, magnesium concentrations, and urine calcium levels. The limitations of conventional therapy include wide fluctuations in serum calcium, high pill burden, poor quality of life, and renal complications. Parathyroid hormone (PTH) replacement therapy may improve the biochemical profile in those in whom conventional therapy proves unsatisfactory. Based on a systematic review and meta-analysis of the literature, the panel made a graded recommendation suggesting conventional therapy as first line therapy rather than administration of PTH (weak recommendation, low quality evidence). When conventional therapy is deemed unsatisfactory, the panel considers use of PTH. Because pregnancy and lactation are associated with changes in calcium homeostasis, close monitoring is required during these periods with appropriate adjustment of calcium and active vitamin D analogue therapy to ensure that serum calcium remains in the mid to low normal reference range in order to avoid maternal and fetal complications. Emerging therapies include molecules with prolonged PTH action as well as different mechanisms of action that may significantly enhance drug efficacy and safety. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

1 December 2020 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
LYLiang Yao
Liang Yao
XHXu Hui
Xu Hui
MLMeixuan Li
Meixuan Li
JLJing Li
Jing Li
MAMuhammad Muneeb Ahmed
Muhammad Muneeb Ahmed
Gordon GuyattGordon Guyatt
Gordon Guyatt
The complications and symptoms of hypoparathyroidism remain incompletely defined. Measuring serum parathyroid hormone (PTH) and calcium levels early after total thyroidectomy may predict the development of chronic hypoparathyroidism. The study aimed (i) to identify symptoms and complications associated with chronic hypoparathyroidism and determine the prevalence of those symptoms and complications (Part I), and (ii) to examine the utility of early postoperative measurements of PTH and calcium in predicting chronic hypoparathyroidism (Part II). We searched Medline, Medline In-Process, EMBASE, and Cochrane CENTRAL to identify complications and symptoms associated with chronic hypoparathyroidism. We used two predefined criteria (at least three studies reported the complication and symptom and had statistically significantly greater pooled relative estimates). To estimate prevalence, we used the median and interquartile range (IQR) of the studies reporting complications and symptoms. For testing the predictive values of early postoperative measurements of PTH and calcium, we used a bivariate model to perform diagnostic test meta-analysis. In Part I, the 93 eligible studies enrolled a total of 18,973 patients and reported on 170 complications and symptoms. We identified nine most common complications or symptoms probably associated with chronic hypoparathyroidism. The complications or symptoms and the prevalence are as follows: nephrocalcinosis/nephrolithiasis (median prevalence among all studies 15%), renal insufficiency (12%), cataract (17%), seizures (11%), arrhythmia (7%), ischemic heart disease (7%), depression (9%), infection (11%), and all-cause mortality (6%). In Part II, 18 studies with 4325 patients proved eligible. For PTH measurement, regarding the posttest probability, PTH values above 10 pg/mL 12–24 hours postsurgery virtually exclude chronic hypoparathyroidism irrespective of pretest probability (100%). When PTH values are below 10 pg/mL, posttest probabilities range from 3% to 64%. Nine complications and symptoms are probably associated with chronic hypoparathyroidism. A PTH value above a threshold of 10 pg/mL 12–24 hours after total thyroidectomy is a strong predictor that the patients will not develop chronic hypoparathyroidism. Patients with PTH values below the threshold need careful monitoring as some will develop chronic hypoparathyroidism. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).

15 December 2023 in BMJ
Verified
Journal Article
Open access
PDF file
LYLiang Yao
Liang Yao
BSBehnam Sadeghirad
Behnam Sadeghirad
MLMeixuan Li
Meixuan Li
JLJing Li
Jing Li
QWQi Wang
Qi Wang
JBJason W Busse
Jason W Busse
Objective: We explored the comparative effectiveness of available therapies for chronic pain associated with temporomandibular disorders (TMD). Design: Systematic review and network meta-analysis of randomised clinical trials (RCTs). Data sources: MEDLINE, EMBASE, CINAHL, CENTRAL, and SCOPUS were searched to May 2021, and again in January 2023. Study selection: Interventional RCTs that enrolled patients presenting with chronic pain associated with TMD. Data extraction and synthesis: Pairs of reviewers independently identified eligible studies, extracted data, and assessed risk of bias. We captured all reported patient-important outcomes, including pain relief, physical functioning, emotional functioning, role functioning, social functioning, sleep quality, and adverse events. We conducted frequentist network meta-analyses to summarise the evidence and used the GRADE approach to rate the certainty of evidence and categorise interventions from most to least beneficial. Results: 233 trials proved eligible for review, of which 153—enrolling 8713 participants and exploring 59 interventions or combinations of interventions—were included in network meta-analyses. All subsequent effects refer to comparisons with placebo or sham procedures. Effects on pain for eight interventions were supported by high to moderate certainty evidence. The three therapies probably most effective for pain relief were cognitive behavioural therapy (CBT) augmented with biofeedback or relaxation therapy (risk difference (RD) for achieving the minimally important difference (MID) in pain relief of 1 cm on a 10 cm visual analogue scale: 36% (95% CI 33 to 39)), therapist-assisted jaw mobilisation (RD 36% (95% CI 31 to 40)), and manual trigger point therapy (RD 32% (29 to 34)). Five interventions were less effective, yet more effective than placebo, showing RDs ranging between 23% and 30%: CBT, supervised postural exercise, supervised jaw exercise and stretching, supervised jaw exercise and stretching with manual trigger point therapy, and usual care (such as home exercises, self stretching, reassurance). Moderate certainty evidence showed four interventions probably improved physical functioning: supervised jaw exercise and stretching (RD for achieving the MID of 5 points on the short form-36 physical component summary score: 43% (95% CI 33 to 51)), manipulation (RD 43% (25 to 56)), acupuncture (RD 42% (33 to 50)), and supervised jaw exercise and mobilisation (RD 36% (19 to 51)). The evidence for pain relief or physical functioning among other interventions, and all evidence for adverse events, was low or very low certainty. Conclusion: When restricted to moderate or high certainty evidence, interventions that promote coping and encourage movement and activity were found to be most effective for reducing chronic TMD pain. Registration: PROSPERO (CRD42021258567)

19 February 2025 in BMJ
Verified
Journal Article
Open access
PDF file
XWXiaoqin Wang
Xiaoqin Wang
GMGrace Martin
Grace Martin
BSBehnam Sadeghirad
Behnam Sadeghirad
YCYaping Chang
Yaping Chang
IFIvan D Florez
Ivan D Florez
JBJason W Busse
Jason W Busse
Objective To address the comparative effectiveness of common interventional procedures for chronic non-cancer (axial or radicular) spine pain. Design Systematic review and network meta-analysis (NMA) of randomised controlled trials (RCTs). Data sources Medline, Embase, CINAHL, CENTRAL, and Web of Science from inception to 24 January 2023. Study selection RCTs that enrolled patients with chronic non-cancer spine pain, randomised to receive a commonly used interventional procedure versus sham procedure, usual care, or another interventional procedure. Data extraction and synthesis Pairs of reviewers independently identified eligible studies, extracted data, and assessed risk of bias. We conducted frequentist network meta-analyses to summarise the evidence and used the GRADE approach to rate the certainty of evidence. Results Of 132 eligible studies, 81 trials with 7977 patients that explored 13 interventional procedures or combinations of procedures were included in meta-analyses. All subsequent effects refer to comparisons with sham procedures. For chronic axial spine pain, the following probably provide little to no difference in pain relief (moderate certainty evidence): epidural injection of local anaesthetic (weighted mean difference (WMD) 0.28 cm on a 10 cm visual analogue scale (95% CI −1.18 to 1.75)), epidural injection of local anaesthetic and steroids (WMD 0.20 (−1.11 to 1.51)), and joint-targeted steroid injection (WMD 0.83 (−0.26 to 1.93)). Intramuscular injection of local anaesthetic (WMD −0.53 (−1.97 to 0.92)), epidural steroid injection (WMD 0.39 (−0.94 to 1.71)), joint-targeted injection of local anaesthetic (WMD 0.63 (−0.57 to 1.83)), and joint-targeted injection of local anaesthetic with steroids (WMD 0.22 (−0.42 to 0.87)) may provide little to no difference in pain relief (low certainty evidence); intramuscular injection of local anaesthetic with steroids may increase pain (WMD 1.82 (−0.29 to 3.93)) (low certainty evidence). Evidence for joint radiofrequency ablation proved of very low certainty. For chronic radicular spine pain, epidural injection of local anaesthetic and steroids (WMD −0.49 (−1.54 to 0.55)) and radiofrequency of dorsal root ganglion (WMD 0.15 (−0.98 to 1.28)) probably provide little to no difference in pain relief (moderate certainty evidence). Epidural injection of local anaesthetic (WMD −0.26 (−1.37 to 0.84)) and epidural injection of steroids (WMD −0.56 (−1.30 to 0.17)) may result in little to no difference in pain relief (low certainty evidence). Conclusion Our NMA of randomised trials provides low to moderate certainty evidence that, compared with sham procedures, commonly performed interventional procedures for axial or radicular chronic non-cancer spine pain may provide little to no pain relief. Registration PROSPERO (CRD42020170667)